Noticias de TGTX_US

Noticias del mercado

Últimas noticias sobre TGTX_US — 181 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: TGTX_US ✕ 181 resultados
22/04/2026 TGTX_US — ChartMill
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
22/04/2026 TGTX_US — Sahm
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
21/04/2026 TGTX_US — MarketBeat
HC Wainwright Forecasts Lower Earnings for TG Therapeutics
20/04/2026 TGTX_US — MSN ES ← EN
TG Therapeutics (TGTX) recorta drásticamente un 18% debido a una guía de ventas más baja para 2025
20/04/2026 TGTX_US — DirectorsTalk Interviews
TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 26% Potential Upside in the Biotech Sector
20/04/2026 TGTX_US — ChartMill
TG Therapeutics Inc (NASDAQ:TGTX) Shows Strong Growth and Technical Setup for Potential Upside
18/04/2026 TGTX_US — Sahm
Has The Market Mispriced TG Therapeutics (TGTX) After Recent Biotech Sector Coverage Swings?
18/04/2026 TGTX_US — Seeking Alpha
TG Therapeutics Stock: Flawless Execution $500M Non-Dilutive Boost Outlook (NASDAQ:TGTX)
16/04/2026 TGTX_US — Eastern Progress
TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi
16/04/2026 TGTX_US — TradingView
TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi
16/04/2026 TGTX_US — Yahoo Finance
TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi
15/04/2026 TGTX_US — Xã Thanh Hà ES ← EN
Análisis competitivo de acciones de TG Therapeutics (TGTX) (ganancia marginal) 2026-04-15 - Acciones de Gap Down
15/04/2026 TGTX_US — Stock Titan
MS trial completion moves TG closer to at-home BRIUMVI option
15/04/2026 TGTX_US — Yahoo Finance
TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous BRIUMVI
15/04/2026 TGTX_US — Investing.com
TG Therapeutics completes enrollment in subcutaneous BRIUMVI trial
15/04/2026 TGTX_US — Investing.com
TG Therapeutics completes enrollment in subcutaneous BRIUMVI trial By Investing.com
06/04/2026 TGTX_US — DirectorsTalk Interviews
TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring A 32.5% Upside Potential In Biotech
05/04/2026 TGTX_US — MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts
04/04/2026 TGTX_US — ChartMill
TG Therapeutics Inc (NASDAQ:TGTX): An Affordable Growth Stock with Strong Momentum
31/03/2026 TGTX_US — Seeking Alpha
TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting Downside (TGTX)

Página 7 de 10

keyboard_arrow_up